Aventis Pharmaceuticals Products Inc.
26Patents
0Active
26Granted
32Portfolio score
Filing activity: May 8, 1995 → Mar 30, 2001
Most-cited patents
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US6180632A | Quinoline and quinoxaline compounds which inhibit platelet-derived growth factor and/or p56lck tyrosine kinases | Chemistry; Metallurgy | 232 | Expired |
| US6245760A | Quinoline and quinoxaline compounds which inhibit platelet-derived growth factor and/or p56lck tyrosine kinases | Chemistry; Metallurgy | 206 | Expired |
| US6159978A | Quinoline and quinoxaline compounds which inhibit platelet-derived growth factor and/or p56.sup.lck tyrosine kinases | Chemistry; Metallurgy | 188 | Expired |
| US6057320A | Bis mono-and bicyclic aryl and heteroaryl compounds which inhibit EGF and/or PDGF receptor tyrosine kinase | Chemistry; Metallurgy | 84 | Expired |
| US6080767A | Substituted n-[(aminoiminomethyl or aminomethyl)phenyl]propyl amides | Chemistry; Metallurgy | 59 | Expired |
| USRE37650E1 | Aryl and heteroaryl quinazoline compounds which inhibit CSF-1R receptor tyrosine kinase | General | 59 | Expired |
| US6323227A | Substituted N-[(aminoiminomethyl or aminomethyl)phenyl]propyl amides | Chemistry; Metallurgy | 42 | Expired |
| US6103705A | Pharmaceutical composition comprising a compound having anti-Xa activity and a platelet aggregation antagonist compound | Human Necessities | 22 | Expired |
| US6258596A | Variants of apolipoprotein A-I | Chemistry; Metallurgy | 19 | Expired |
| US6307054A | Process for preparing 2,4- dihydroxypyridine and 2,4- dihydroxy-3-nitropyridine | Chemistry; Metallurgy | 9 | Expired |
| US6153588A | Stable non-hygroscopic crystalline form of N-[N-[N-4-(piperidin-4-yl)butanoyl)-N-ethylglycyl] aspartyl]-L-.beta.-cyclohexyl alanine amide | Emerging Cross-Sectional Technologies | 7 | Expired |
| US6133409A | Process for the solid phase synthesis of aldehyde, ketone, oxime, amine, hydroxamic acid and .alpha..beta.-unsaturated carboxylic acid and aldehyde compounds | Chemistry; Metallurgy | 4 | Expired |
| US6391980B1 | Activated and conjugated polystyrene substrate | Emerging Cross-Sectional Technologies | 4 | Expired |
| US6127515A | Functionalized resin for the synthesis of amides and peptides | Chemistry; Metallurgy | 2 | Expired |
| US6140504A | Substituted intermediate compounds for the preparation of n-[(aminoiminomethyl or aminomethyl)phenyl]propyl amides | Chemistry; Metallurgy | 2 | Expired |
| US6277865A | Piperididinyl and N-amidinopiperidinyl derivatives | Chemistry; Metallurgy | 2 | Expired |
| US6143894A | Preparation of [1S-[1A,2B,3B,4A(S*)]]-4-[7-[[1-(3-chloro-2-thienyl)methyl propyl]amino] -3H-imidazo[4,5-B]pyridin-3-yl]-N-ethyl-2,3-dihydroxycyclopentanecarboxa mide | Chemistry; Metallurgy | 1 | Expired |
| US6361936B1 | Activated and conjugated polystyrene substrate | Emerging Cross-Sectional Technologies | 1 | Expired |
| US6306873A | Substituted .beta.-thiocarboxylic acids | Chemistry; Metallurgy | 1 | Expired |
| US6184382A | Process for preparing N6-substituted adenosine derivatives | Chemistry; Metallurgy | 1 | Expired |
| US6180759A | Process for the preparation of azacycloalkylakanoyl pseudotetrapeptides | Emerging Cross-Sectional Technologies | 1 | Expired |
| US6235909A | Preparation of is-[1A,2B,3B,4A(S*)]-4-[7-[[1-(3-chloro-2-Thienyl)methyl]amino]-3H-imidazo [4,5-B]pyridin-3-YL]-N-ethyl-2,3-dihydroxycyclopentanecarboxamide | Chemistry; Metallurgy | 1 | Expired |
| US7041497B2 | Nuclear factor κB inducing factor | Human Necessities | 0 | Expired |
| USRE37850E1 | Recombinant human endothelial cell growth factor | General | 0 | Expired |
| US6274705A | Antithrombotic azacycloalkylalkanoyl peptides and pseudopeptides | Chemistry; Metallurgy | 0 | Expired |
Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.